Journal of Endocrinological Investigation, Journal Year: 2022, Volume and Issue: 46(4), P. 795 - 804
Published: Oct. 28, 2022
Language: Английский
Sexual Medicine Reviews, Journal Year: 2021, Volume and Issue: 10(2), P. 271 - 285
Published: Nov. 20, 2021
Language: Английский
Citations
54
Frontiers in Endocrinology, Journal Year: 2021, Volume and Issue: 12
Published: June 16, 2021
Endocrine diseases have a considerable impact on public health from an epidemiological point of view and because they may cause long-term disability, alteration the quality-of-life affected patients, are fifth leading death. In this extensive review literature, we evaluated prevalence different disorders endocrine interest in world Italy, highlighting their epidemiological, clinical, economic impact.
Language: Английский
Citations
44
International Journal of Clinical Practice, Journal Year: 2022, Volume and Issue: 2022, P. 1 - 10
Published: March 20, 2022
Objectives.
Assessment
of
erectile
dysfunction
(ED)
burden
could
improve
health
outcomes
associated
with
underlying
cardiometabolic
and
psychological
causes
ED.
This
study
provided
updated
real-world
evidence
(RWE)
on
ED
epidemiology
quantified
healthcare
resource
utilization
(HCRU)
health-related
quality
life
(HRQoL)
among
men
in
the
UK.
Methods.
cross-sectional,
prospective
was
conducted
via
a
self-reported
Internet
survey
2018
UK
general
population.
Prevalence
estimated;
HCRU
HRQoL
were
compared
between
versus
without
bivariate
analysis.
Results.
Of
12,490
included,
41.5%
reported
ED;
7.5%
severe
most
prevalent
Wales
(44.3%).
Men
older
(54.1
±
14.5
vs.
46.8
14.1
years)
often
modifiable
lifestyle
risk
factors,
including
smoking
(32.8%
26.3%),
drinking
alcohol
(76.1%
71.0%),
not
exercising
(21.7%
19.4%),
being
overweight
or
obese
(64.9%
54.6%).
Additionally,
more
≥1
comorbid
chronic
conditions
(73.7%
47.7%),
hypertension
(31.8%
16.3%),
hyperlipidemia
(27.6%
14.0%),
depression
(24.3%
14.6%),
anxiety
(23.3%
16.6%),
diabetes
(15.9%
6.1%)
(all,
<
0.001).
Nearly
half
(45.3%)
undergoing
treatment
for
comorbidities.
Furthermore,
visit
to
physicians/nurse
practitioners
pharmacists
past
year
had
significantly
lower
SEAR
total
domain
scores
than
id="M2">
Language: Английский
Citations
36
The Aging Male, Journal Year: 2022, Volume and Issue: 25(1), P. 202 - 216
Published: Aug. 4, 2022
Purpose: COVID-19, a novel infection, presented with several complications, including socioeconomical and reproductive health challenges such as erectile dysfunction (ED). The present review summarizes the available shreds of evidence on impact COVID-19 ED.Materials methods: All published peer-reviewed articles from onset outbreak to date, relating ED, were reviewed. Results: Available pieces that ED is consequence are convincing. share common risk factors disruption vascular integrity, cardiovascular disease (CVD), cytokine storm, diabetes, obesity, chronic kidney (CKD). also induces impaired pulmonary haemodynamics, increased ang II, testicular damage low serum testosterone, reduced arginine-dependent NO bioavailability promotes reactive oxygen species (ROS) generation endothelial dysfunction, resulting in ED. In addition, triggers psychological/mental stress suppresses testosterone-dependent dopamine concentration, which contributes incident ED.Conclusions: conclusion, exerts detrimental effect male function, function. This involves cascade events multiple pathways. As pandemic dwindles, identifying long-term effects COVID-19-induced proffering adequate effective measures militating against remains pertinent.
Language: Английский
Citations
36
Endocrine, Journal Year: 2024, Volume and Issue: 85(1), P. 44 - 66
Published: Feb. 12, 2024
Studies investigating the effects of SARS-CoV-2 on male reproductive function are few and heterogeneous, results often conflicting. This systematic review meta-analysis was carried out studies conducted in men with active or anamnestic infection to evaluate its consequences sex hormone profile semen parameters.
Language: Английский
Citations
7
Sexual Medicine Reviews, Journal Year: 2021, Volume and Issue: 10(2), P. 286 - 310
Published: Sept. 20, 2021
COVID-19 infection is expected to be associated with an increased likelihood of erectile dysfunction (ED). Considering the high transmissibility COVID-19, ED may a concerning consequence for large segment population. To (1) summarize existing published evidence impact on prevalence, severity, treatment, and management ED; (2) identify health-related trends in emerging literature gaps research make recommendations future needs area. A scoping search was conducted April 27, 2021. The Preferred Reporting Items Systematic Reviews Meta-Analyses Extension Scoping (Preferred Meta-Analyses-ScR) checklist followed. performed PubMed using terms: erectile, sexual, dysfunction. total 693 publications were screened relevance. Studies appraised their level based study design rigor methodology. that causes or impacts compelling. Four topics emerged regarding nature association between ED: biological mental health (3) access treatment; (4) disparities ED. Long-term well-designed studies are needed clarify extent pandemic exposed several vulnerabilities within worldwide healthcare social systems. has uniquely harmful men's function through biological, health, mechanisms. As wanes, strategies long-term effects additional care support adequately mitigate health. Hsieh T-C, Edwards NC, Bhattacharyya SK, et al.The Epidemic COVID-19-Related Erectile Dysfunction: Review Health Care Perspective. Sex Med Rev 2022;10:286–310.
Language: Английский
Citations
37
Journal of Endocrinological Investigation, Journal Year: 2021, Volume and Issue: 45(4), P. 859 - 864
Published: Nov. 30, 2021
Language: Английский
Citations
34
Reviews in Endocrine and Metabolic Disorders, Journal Year: 2021, Volume and Issue: 23(2), P. 215 - 231
Published: Aug. 13, 2021
Besides the pulmonary manifestations caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can heavily impact on severity of syndrome, has been recently associated with disease 2019 (COVID-19). Patients pituitary diseases or gland itself may also be involved in COVID-19 clinical presentation and/or severity, causing apoplexy.Moreover, hypopituitarism is frequently burdened several metabolic complications, including arterial hypertension, hyperglycemia, obesity and vertebral fractures, have all poor outcomes increased mortality patients infected SARS-CoV-2.This review will discuss as a condition that might bidirectional relationship due to frequent presence comorbidities, direct indirect damage being per se potential risk factor for COVID-19. Finally, we address current recommendations management vaccines adrenal insufficiency.
Language: Английский
Citations
33
Sexual Medicine Reviews, Journal Year: 2022, Volume and Issue: 10(4), P. 714 - 753
Published: June 29, 2022
Language: Английский
Citations
24
Journal of Endocrinological Investigation, Journal Year: 2022, Volume and Issue: 45(4), P. 691 - 703
Published: Jan. 8, 2022
Language: Английский
Citations
23